Plasma procalcitonin in rheumatic diseases

Plasma procalcitonin in rheumatic diseases

Data on the origin and biological function of procalcitonin, the pro-hormone of calcitonin, are scarce. Since this peptide can be induced in bacterial invasive infections, serum procalcitonin levels may be useful in differential diagnosis of systemic inflammatory response syndrome. This review will...

Full description

Bibliographic Details
Main Authors:	C.A. Scirè, R. Caporali, C. Perotti, C. Montecucco
Format:	Article
Language:	English
Published:	PAGEPress Publications 2003-06-01
Series:	Reumatismo
Online Access:	https://reumatismo.org/index.php/reuma/article/view/116

Similar Items

PROCALCITONIN TEST IN RHEUMATIC DISEASES
by: G. M. Tarasova, et al.
Published: (2014-09-01)

Significance of serum procalcitonin for differentiating infections from rheumatic diseases
by: G. M. Tarasova, et al.
Published: (2018-11-01)

The role of the procalcitonin test in the diagnosis of infections in immune-mediated inflammatory rheumatic diseases
by: N. V. Muravyeva, et al.
Published: (2019-12-01)

The plasma viscosity test in chronic rheumatic disease
by: Cowan, I. C.
Published: (1951)

Providing updated guidelines for the management of rheumatic diseases in Italy with the ADAPTE methodology: a project by the Italian Society for Rheumatology
by: M. Manara, et al.
Published: (2019-09-01)

Procalcitonin and Neopterin in Infectious Diseases
by: Wiedermann Franz J., et al.
Published: (1999-08-01)

Plasma Procalcitonin Is Useful for Predicting the Severity of Acute Cholecystitis
by: Saben Sakalar, et al.
Published: (2020-01-01)

Significance of procalcitonin concentration in blood plasma in septic state diagnostic
by: V.V. Morrison, et al.
Published: (2010-06-01)

The diagnostic ability of plasma Procalcitonin levels in Gram positive bacteremia
by: Y Koizumi, et al.
Published: (2020-02-01)

Rheumatic masks of plasma cell dyscrasias
by: Vladimir Ivanovich Vasilyev, et al.
Published: (2012-04-01)

Costs of treatment with biologic and targeted synthetic disease-modifying anti-rheumatic drugs in rheumatic diseases – data from the Romanian Registry of Rheumatic Diseases
by: Catalin Codreanu, et al.
Published: (2020-03-01)

Targeting Syk in autoimmune rheumatic diseases
by: GUO-MIN eDENG, et al.
Published: (2016-03-01)

Procalcitonin and Inflammatory Cytokines in Children with Asthma
by: M. Emporiadou, et al.
Published: (2005-05-01)

Vitamin D and rheumatic diseases
by: M. Rossini, et al.
Published: (2014-07-01)

PREVENTION OF RHEUMATIC HEART DISEASE AND RHEUMATIC FEVER
by: Namrata Khanal
Published: (2003-01-01)

Performance of the 2010 classification criteria for rheumatoid arthritis: a systematic literature review and a meta-analysis.
by: Garifallia Sakellariou, et al.
Published: (2013-01-01)

Therapeutic plasma exchange in rheumatic diseases: a university hospital experience
by: Juan Pablo Córdoba, et al.

Plasma-exchange in the treatment of systemic rheumatic diseases: past and present experience
by: P. Marson, et al.
Published: (2011-06-01)

Plasma procalcitonin concentrations predict organ dysfunction and outcome in dogs with sepsis
by: Roberta Troia, et al.
Published: (2018-03-01)

Biotechnological Drugs: The Breakthrough in Autoimmune Rheumatic Conditions
by: Lorenzo Cavagna, et al.
Published: (2014-01-01)

Management of Rheumatic Heart Diseases in Burundi
by: E. Ndirahisha, et al.
Published: (2019-12-01)

The worldwide epidemiology of acute rheumatic fever and rheumatic heart disease
by: Michael D Seckeler, et al.
Published: (2011-02-01)

Pneumonia in rheumatic diseases
by: B S Belov, et al.
Published: (2009-06-01)

Differential kinetics of plasma procalcitonin levels in cerebral malaria in urban Senegalese patients according to disease outcome
by: Babacar Mbengue, et al.
Published: (2011-11-01)

Survey Of Relationship Between Serum Procalcitonin And Infectious Diseases
by: M Rahimkhani, et al.
Published: (2011-03-01)

Survey Of Relationship Between Serum Procalcitonin And Infectious Diseases
by: M Rahimkhani, et al.
Published: (2011-12-01)

Rheumatic fever and rheumatic heart disease in Bangladesh: A review
by: A.K.M. Monwarul Islam, et al.
Published: (2016-01-01)

Contraception for adolescents with chronic rheumatic diseases
by: Benito Lourenço, et al.

Serum Procalcitonin in Chronic Obstructive Pulmonary Disease
by: Farzaneh Akbari, et al.
Published: (2021-03-01)

Diffuse alveolar hemorrhage as a manifestation of Behçet disease
by: V. Grosso, et al.
Published: (2013-07-01)

Rheumatic diseases and multimorbidity
by: E L Nasonov, et al.
Published: (2015-05-01)

MicroRNAs in autoimmune rheumatic diseases
by: G.D. Sebastiani, et al.
Published: (2012-03-01)

Radiosynovectomy in rheumatic diseases
by: Jarosław B. Ćwikła, et al.
Published: (2014-09-01)

The macrophages in rheumatic diseases
by: Laria A, et al.
Published: (2016-02-01)

Comparison of the novel ARCHITECT procalcitonin assay with established procalcitonin assay systems
by: A. Soh, et al.
Published: (2018-11-01)

Osteoporosis and rheumatic diseases
by: N. Maruotti, et al.
Published: (2014-06-01)

Histopathology of the synovial tissue: perspectives for biomarker development in chronic inflammatory arthritides
by: A. Manzo, et al.
Published: (2018-10-01)

Autoimmune Rheumatic Diseases
by: Juan-Manuel Anaya, et al.
Published: (2014-01-01)

Pulmonary thromboembolism in children with rheumatic diseases
by: Vogler Larry B, et al.
Published: (2012-07-01)

Primary myelofibrosis in rheumatic diseases
by: Vladimir Ivanovich Vasilyev, et al.
Published: (2013-04-01)

Cannot write session to /tmp/vufind_sessions/sess_psth7cv8ndbnfqhcktgjl5ogl2